Company Active LTD

Company profile

Multiomic Health Limited

Multiomic Health - AI-Enabled Precision Medicine for Metabolic Syndrome

AI-Enabled Precision Medicine for Metabolic Syndrome

CRN
13246608
Founded
2021
Age
5

Overview

Legal name
MULTIOMIC HEALTH LIMITED
Region
London
Registered address
36 ROTHERWOOD ROAD
LONDON
ENGLAND
SW15 1JZ
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
14 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

30 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

05 Mar
2021

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
2 years

Projects

2023 Collaborative R&D Lead participant

Transforming Diabetic Kidney Disease Care: Harnessing Integrative Multi-Omics Analysis for Precision Diagnosis and Management

1 Dec 2023 to 30 Nov 2025

Awarded
£501,894
Total cost £716,992

A recent report published by Kidney Research UK found that kidney disease costs the UK economy £7bn/year, £6.4bn of which as direct costs to the NHS. Without significant government intervention, the report states these costs could rise to £13.9bn by 2033\. Diabetic kidney disease (DKD) is the most common form of kidney disease, caused by damage to the kid...

Product types

Collaborative R&D